Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,634,158
+$1,386,370 QoQ
Shares Held
66,103
-5.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#691
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDGAR LOMAX CO/VA holds $161,967,278 across 7 Drug Manufacturers - General names. ABBV ranks #7 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
1,365,777 | $32,887,910 | |
| 2 | JNJ |
Johnson & Johnson
|
125,880 | $31,969,743 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
461,275 | $26,578,665 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
147,640 | $18,652,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
143,985 | $18,502,072 | |
| 6 | AMGN |
Amgen Inc
|
46,233 | $16,741,893 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
66,103 | $16,634,158 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,634,158 | 66,103 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,247,788 | 70,108 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,763,559 | 20,848 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,944,073 | 21,353 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,126,453 | 27,618 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,880,807 | 28,068 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,474,622 | 64,573 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,004,650 | 65,853 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,470,914 | 66,878 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,327,805 | 67,698 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,981,574 | 51,504 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,982,759 | 53,554 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,346,692 | 54,529 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,808,061 | 55,268 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,228,339 | 69,478 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,374,300 | 69,848 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,759,183 | 70,248 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $11,066,925 | 68,268 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $37,553,596 | 277,353 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $30,217,407 | 280,128 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $31,951,237 | 283,658 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $31,430,659 | 290,433 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,259,062 | 123,743 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $11,031,347 | 125,943 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,864,365 | 120,843 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $9,016,553 | 118,343 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||